Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 25, Pages 3599-3608
Publisher
Springer Nature
Online
2017-02-07
DOI
10.1038/onc.2016.516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
- (2015) Thomas Condamine et al. Annual Review of Medicine
- The yin and yang of evasion and immune activation in HCC
- (2015) Oxana V. Makarova-Rusher et al. JOURNAL OF HEPATOLOGY
- IL-6-stimulated CD11b+ CD14+ HLA-DR− myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus
- (2015) Miao-Fen Chen et al. Oncotarget
- Chemerin suppresses murine allergic asthma by inhibiting CCL2 production and subsequent airway recruitment of inflammatory dendritic cells
- (2014) L. Zhao et al. ALLERGY
- A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis
- (2014) Shicheng Su et al. CANCER CELL
- Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization
- (2014) Yuli Lin et al. Cellular & Molecular Immunology
- The E3 Ubiquitin Ligase Pellino3 Protects against Obesity-Induced Inflammation and Insulin Resistance
- (2014) Shuo Yang et al. IMMUNITY
- Impact of Serum Chemerin Levels on Liver Functional Reserves and Platelet Counts in Patients with Hepatocellular Carcinoma
- (2014) Kenji Imai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2014) J.-I. Youn et al. JOURNAL OF IMMUNOLOGY
- The two faces of IL-6 in the tumor microenvironment
- (2014) Daniel T. Fisher et al. SEMINARS IN IMMUNOLOGY
- Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
- (2013) Fumitaka Arihara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells
- (2012) A. Tsuyada et al. CANCER RESEARCH
- Natural killer cells in liver disease
- (2012) Zhigang Tian et al. HEPATOLOGY
- The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses
- (2012) Russell K. Pachynski et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Expression, Regulation, and Function of Atypical Chemerin Receptor CCRL2 on Endothelial Cells
- (2012) J. Monnier et al. JOURNAL OF IMMUNOLOGY
- Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection
- (2011) John R. Teijaro et al. CELL
- Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism
- (2011) Benjamin Bondue et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver
- (2011) Josef Wanninger et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- HCC and angiogenesis: possible targets and future directions
- (2011) Andrew X. Zhu et al. Nature Reviews Clinical Oncology
- ChemR23 Dampens Lung Inflammation and Enhances Anti-viral Immunity in a Mouse Model of Acute Viral Pneumonia
- (2011) Benjamin Bondue et al. PLoS Pathogens
- Identification of chemerin receptor (ChemR23) in human endothelial cells: Chemerin-induced endothelial angiogenesis
- (2010) Jaspreet Kaur et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- NF-κB and STAT3 – key players in liver inflammation and cancer
- (2010) Guobin He et al. CELL RESEARCH
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
- (2010) Cesar A. Corzo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
- (2010) Thomas Condamine et al. TRENDS IN IMMUNOLOGY
- Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF
- (2009) Luigi Dolcetti et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B
- (2009) Vincent Wai-Sun Wong et al. INTERNATIONAL JOURNAL OF CANCER
- Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients
- (2009) Jing-Ping Zhang et al. JOURNAL OF HEPATOLOGY
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells
- (2008) Bastian Hoechst et al. GASTROENTEROLOGY
- High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma
- (2008) Xiao-Dong Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment
- (2008) Cristina Albanesi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis
- (2008) Brian A. Zabel et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More